Flexible warped nano-graphene shows promise for fluorescent cell imaging
An international team of scientists has developed a water-soluble warped nanographene, that is biocompatible and shows promise for fluorescent cell imaging...
List view / Grid view
News
FDA expands approval of Imfinzi to reduce the risk of NSCLC progression
The FDA has approved Imfinzi for the treatment of patients with stage III non-small cell lung cancer whose tumours are not able to be surgically removed and whose cancer has not progressed after treatment...
Blood and urine tests developed to indicate autism in children
International researchers believe that their new blood and urine tests which search for damage to proteins are the first of their kind to detect early autism spectrum disorders...
Donepezil restores the density of dendritic spines after alcohol binges
Alzheimer's drug appears to reverse structural and genetic brain changes that affect memory and learning...
Diffusion kurtosis imaging differentiates benign breast lesions from malignancies
An MRI technique that requires no contrast agent, combined with sophisticated data analysis, could reduce the number of unnecessary breast biopsies...
Nusinersen improves motor function of children with SMA
Clinical trial shows treatment is effective for children with spinal muscular atrophy...
TB vaccine trial results offer potential for BCG revaccination
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
Psoriasis drug found to reduce aortic vascular inflammation
An antibody used to treat the skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events...
The future of cell culture: A new continuous bioprocess developed
A technique which allows the continuous production and collection of a cell has been developed removing the limit on the number of cells that can be grown in a culture dish...
We are proud to announce the opening of our North America office: Exciting times for FPS
In order to support the continued growth of our business in North America, FPS opened a new office in Philadelphia, PA and appointed Frederic Le Pape as General Manager...
Short-acting asthma relievers linked to infertility
New research indicates that women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women...
NICE approves Lenvima for differentiated thyroid cancer
NICE has issued its final appraisal decision recommending reimbursement of Lenvima for the treatment of progressive, locally advanced or metastatic, differentiated thyroid carcinoma...
Individual Inks by Hapa Ink
Hapa Ink is a division of Hapa, the innovative on demand printing specialist. It is experiencing a rapid increase in demand of sales for individually developed inks...
Wickham Labs to exhibit at inaugural Making Pharmaceuticals Europe Conference 2018
Wickham Laboratories Ltd will exhibit on Stand 408 at the Making Pharmaceuticals Europe Conference, from the 13 - 14 March 2018 in Belgium at Brussels Expo centre...
Novartis forms alliance to develop medicines for cryptosporidiosis
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance the development of Novartis' drug candidate KDU731...
